hydroxyindoleacetic acid has been researched along with Dyskinesia, Medication-Induced in 27 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Interest in serotonergic involvement in Parkinson's disease (PD) has focussed recently on the possibility that the remaining serotonin neurons innervating striatum (caudate and putamen) might release dopamine as a 'false transmitter'--an action that could have both beneficial and harmful (e." | 1.35 | Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. ( Chang, LJ; Furukawa, Y; Guttman, M; Hornykiewicz, O; Kish, SJ; Rajput, A; Tong, J, 2008) |
| "Rats treated with haloperidol at a dose of 1 mg/kg twice a day for 2 weeks displayed VCMs with twitching of facial musculature that increased in a time dependent manner as the treatment continued to 5 weeks." | 1.34 | Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats. ( Haleem, DJ; Haleem, MA; Samad, N, 2007) |
| "Present study was designed to monitor the responsiveness of 5HT (5-Hydroxytryptamine) -2C receptors following the long-term administration of haloperidol in rats." | 1.34 | Neurochemical and behavioral effects of m-CPP in a rat model of tardive dyskinesia. ( Haleem, DJ; Ikram, H; Samad, N, 2007) |
| " Pretreatment with 5,7-dihydroxytryptamine (5,7-DHT) suppressed the allylnitrile-induced head twitching, and decreased the contents of 5-HT and 5-HIAA in almost all areas of the brain throughout the observation period, as well as the ratio of 5-HIAA/5-HT in the medulla oblongata plus pons from 1 to 30 days after dosing with allylnitrile." | 1.29 | Involvement of noradrenergic and 5-hydroxytryptaminergic systems in allylnitrile-induced head twitching. ( Hashimoto, K; Huang, J; Tanii, H, 1993) |
| "Rats treated with anisomycin alone also showed significant increases in striatal 5-HT and 5-HIAA concentrations which were somewhat higher on the side of the ICV infusions." | 1.28 | The protein synthesis inhibitor, anisomycin, causes exacerbation of the iminodipropionitrile-induced spasmodic dyskinetic syndrome in rats. ( Cadet, JL; Fahn, S; Jackson-Lewis, V; Katz, M; Stennett, R, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (55.56) | 18.7374 |
| 1990's | 6 (22.22) | 18.2507 |
| 2000's | 6 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dupre, KB | 2 |
| Eskow, KL | 2 |
| Steiniger, A | 1 |
| Klioueva, A | 1 |
| Negron, GE | 1 |
| Lormand, L | 1 |
| Park, JY | 2 |
| Bishop, C | 3 |
| Barnum, CJ | 1 |
| Dickinson, SO | 1 |
| Taylor, JL | 1 |
| Walker, PD | 1 |
| Haleem, DJ | 2 |
| Samad, N | 2 |
| Haleem, MA | 1 |
| Ikram, H | 1 |
| Kish, SJ | 1 |
| Tong, J | 1 |
| Hornykiewicz, O | 1 |
| Rajput, A | 1 |
| Chang, LJ | 1 |
| Guttman, M | 1 |
| Furukawa, Y | 1 |
| Ogawa, T | 1 |
| Nagao, T | 3 |
| Kashiwabara, K | 1 |
| Fujiwara, Y | 1 |
| Harada, T | 1 |
| Otsuki, S | 3 |
| Jeste, DV | 2 |
| Doongaji, DR | 1 |
| Linnoila, M | 1 |
| Akiyama, K | 1 |
| Yamamoto, M | 1 |
| Fujimoto, A | 1 |
| Ebara, T | 1 |
| Sato, M | 2 |
| Tanii, H | 2 |
| Huang, J | 1 |
| Hashimoto, K | 2 |
| Szymanski, S | 1 |
| Lieberman, J | 2 |
| Pollack, S | 2 |
| Munne, R | 1 |
| Safferman, A | 1 |
| Kane, J | 2 |
| Kronig, M | 1 |
| Cooper, T | 2 |
| Fornai, F | 1 |
| Alessandri, MG | 1 |
| Saginario, A | 1 |
| Vaglini, F | 1 |
| Corsini, GU | 1 |
| Winsberg, BG | 2 |
| Hurwic, MJ | 2 |
| Perel, J | 1 |
| Sverd, J | 1 |
| Klutch, A | 1 |
| Roccatagliata, G | 2 |
| Albano, C | 2 |
| Besio, G | 1 |
| Ohshimo, T | 1 |
| Mitsunobu, K | 1 |
| Cocito, L | 1 |
| Maffini, M | 1 |
| Bowers, MB | 1 |
| Moore, D | 1 |
| Tarsy, D | 1 |
| Lohr, JB | 1 |
| Kuczenski, R | 1 |
| Bracha, HS | 1 |
| Moir, M | 1 |
| Bankiewicz, KS | 1 |
| Plunkett, RJ | 1 |
| Mefford, I | 1 |
| Kopin, IJ | 1 |
| Oldfield, EH | 1 |
| Okayama, A | 1 |
| Yamatodani, A | 1 |
| Hayashi, M | 1 |
| Saito, T | 1 |
| Ishizawa, H | 1 |
| Tsuchiya, F | 1 |
| Ozawa, H | 1 |
| Takahata, N | 1 |
| Cadet, JL | 2 |
| Jackson-Lewis, V | 2 |
| Fahn, S | 2 |
| Lu, RB | 1 |
| Ko, HC | 1 |
| Lin, WL | 1 |
| Lin, YT | 1 |
| Ho, SL | 1 |
| Stennett, R | 1 |
| Katz, M | 1 |
| Johns, C | 1 |
| Stahl, SM | 1 |
| Faull, KF | 1 |
| Barchas, JD | 1 |
| Berger, PA | 1 |
3 trials available for hydroxyindoleacetic acid and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
CSF monoamine metabolism in patients with tardive dyskinesia: effect of oxypertine and hydroxyzine pamoate.
Topics: Biogenic Amines; Clinical Trials as Topic; Cyclic AMP; Cyclic GMP; Dyskinesia, Drug-Induced; Female; | 1983 |
The dopamine-serotonin relationship in clozapine response.
Topics: Adolescent; Adult; Antipsychotic Agents; Clozapine; Dopamine; Drug Resistance; Dyskinesia, Drug-Indu | 1993 |
Tardive dyskinesia: a clinical test of the supersensitivity hypothesis.
Topics: Adult; Aged; Clinical Trials as Topic; Cyclic AMP; Depression; Dyskinesia, Drug-Induced; Female; Hom | 1979 |
24 other studies available for hydroxyindoleacetic acid and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Corpus Striatum; Di | 2008 |
The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Hydrox | 2009 |
Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Corpu | 2005 |
Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Buspirone; Chromatography, Hi | 2007 |
Neurochemical and behavioral effects of m-CPP in a rat model of tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Chromatography, High Pressure Liquid; Corpus Striat | 2007 |
Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Caudate Nucleus; Dopamine; Dyskinesia, Drug-Induced; | 2008 |
Tardive dyskinesia and neurotransmitters: effects of sodium valproate, cyproheptadine, oxypertine, hydroxyzine pamoate and Ca-hopantenate on monoamine metabolites, cyclic nucleotides and gamma-aminobutyric acid in human cerebrospinal fluid.
Topics: Adult; Aged; Cyclic AMP; Cyclic GMP; Cyproheptadine; Dyskinesia, Drug-Induced; Female; Homovanillic | 1984 |
Elevated cerebrospinal fluid noradrenaline in tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Homovan | 1984 |
Involvement of noradrenergic and 5-hydroxytryptaminergic systems in allylnitrile-induced head twitching.
Topics: 5,7-Dihydroxytryptamine; Animals; Benzylamines; Dyskinesia, Drug-Induced; Head; Hydroxyindoleacetic | 1993 |
beta,beta'-Iminodipropionitrile-induced persistent dyskinetic syndrome in mice is transiently modified by MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Biogenic Monoamines; Cerebr | 1993 |
Neurochemistry of withdrawal emergent symptoms in children.
Topics: Antipsychotic Agents; Child; Cyclic AMP; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Hydrox | 1977 |
Neurochemistry of withdrawal emergent symptoms in children.
Topics: Antipsychotic Agents; Child; Child, Preschool; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; | 1978 |
[Late chronic dyskinesia from neuroleptic drugs (CSF and pharmacological data) (author's transl)].
Topics: Adult; Antipsychotic Agents; Brain; Dopamine; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; H | 1978 |
Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.
Topics: Adult; Chronic Disease; Cyclic AMP; Cyclic GMP; Cyproheptadine; Dyskinesia, Drug-Induced; Female; Ho | 1979 |
Interactions between central monoaminergic systems: dopamine-serotonin.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Depression; Dopamine; Dyskinesia, Drug-Induced; Female; H | 1979 |
Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; | 1990 |
Behavioral recovery from MPTP-induced parkinsonism in monkeys after intracerebral tissue implants is not related to CSF concentrations of dopamine metabolites.
Topics: Adrenal Medulla; Amnion; Animals; Brain Tissue Transplantation; Caudate Nucleus; Disease Models, Ani | 1990 |
Alterations in the metabolism of serotonin and dopamine in the mouse brain following a single administration of allylnitrile, which induces long-term dyskinesia.
Topics: Administration, Oral; Animals; Brain; Chromatography, High Pressure Liquid; Dopamine; Dyskinesia, Dr | 1991 |
Neurochemical findings in the cerebrospinal fluid of schizophrenic patients with tardive dyskinesia and neuroleptic-induced parkinsonism.
Topics: Adult; Aged; Antipsychotic Agents; Catecholamines; Dopamine; Dyskinesia, Drug-Induced; Epinephrine; | 1986 |
The iminodipropionitrile (IDPN) model of persistent spasmodic dyskinesias: regional serotonin metabolism in rat brain.
Topics: Animals; Brain; Brain Stem; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Hydro | 1988 |
CSF neurochemical study of tardive dyskinesia.
Topics: Acetylcholinesterase; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; | 1989 |
The protein synthesis inhibitor, anisomycin, causes exacerbation of the iminodipropionitrile-induced spasmodic dyskinetic syndrome in rats.
Topics: Animals; Anisomycin; Corpus Striatum; Drug Interactions; Dyskinesia, Drug-Induced; Hydroxyindoleacet | 1989 |
Clozapine pharmacology and tardive dyskinesia.
Topics: Adolescent; Adult; Clozapine; Dibenzazepines; Dyskinesia, Drug-Induced; Epinephrine; Female; Homovan | 1989 |
CSF monamine metabolites in movement disorders and normal aging.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Dyskinesia, Drug-Induced; Dystonia; Female; Glycols; Ho | 1985 |